NIAID Banner Logo Image

HIV Citation List: April 13 - April 26, 2012

Pubmed citations

1. Synthesis and Biological Activity of Potent HIV-1 Protease Inhibitors Based on Phe-Pro Dihydroxyethylene Isosteres. Benedetti, F., F. Berti, S. Budal, P. Campaner, F. Dinon, A. Tossi, R. Argirova, P. Genova, V. Atanassov, and A. Hinkov, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22458611].
[PubMed]. HIV_0413-042612.

2. Sialic acid Associated to αvβ3 Integrin Mediates HIV-1 Tat Interaction and Endothelial Cell Proangiogenic Activation. Chiodelli, P., C. Urbinati, S. Mitola, E. Tanghetti, and M. Rusnati, Journal of Biological Chemistry, 2012. [Epub ahead of print]; PMID[22528484].
[PubMed]. HIV_0413-042612.

3. Synthesis and Biological Evaluation of Novel Small Non-peptidic HIV-1 PIs: The Benzothiophene Ring as an Effective Moiety. Chiummiento, L., M. Funicello, P. Lupattelli, F. Tramutola, F. Berti, and F. Marino-Merlo, Bioorganic & Medicinal Chemistry Letters, 2012. 22(8): p. 2948-2950; PMID[22414613].
[PubMed]. HIV_0413-042612.

4. Structural Insight of HIV-1 Fusion Inhibitor CP621-652 Discovers the Critical Residues for Viral Entry and Inhibition. Chong, H., X. Yao, Z. Qiu, B. Qin, R. Han, S. Waltersperger, M. Wang, S. Cui, and Y. He, Journal of Biological Chemistry, 2012. [Epub ahead of print]; PMID[22511760].
[PubMed]. HIV_0413-042612.

5. Design, Synthesis and Antiviral Activity of Entry Inhibitors that Target the CD4-binding Site of HIV-1. Curreli, F., S. Choudhury, I. Pyatkin, V.P. Zagorodnikov, A.K. Bulay, A. Altieri, Y.D. Kwon, P.D. Kwong, and A.K. Debnath, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22524483].
[PubMed]. HIV_0413-042612.

6. Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against the Initial Autocleavage in Gag-Pol Polyprotein Processing. Davis, D.A., E.E. Soule, K.S. Davidoff, S.I. Daniels, N.E. Naiman, and R. Yarchoan, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22508308].
[PubMed]. HIV_0413-042612.

7. Synthesis, anti-HIV Activity Studies, and in Silico Rationalization of Cyclobutane-fused Nucleosides. Figueras, A., R. Miralles-Lluma, R. Flores, A. Rustullet, F. Busque, M. Figueredo, J. Font, R. Alibes, and J.D. Marechal, ChemMedChem, 2012. [Epub ahead of print]; PMID[22504900].
[PubMed]. HIV_0413-042612.

8. Initial HIV- 1 Antigen-specific CD8+ T cells In Acute HIV-1 Inhibit Transmitted Founder Virus Replication. Freel, S.A., R.A. Picking, G. Ferrari, H. Ding, C. Ochsenbauer, J.C. Kappes, J. Kirchherr, K. Soderberg, K.J. Weinhold, C.K. Cunningham, T. Denny, J.A. Crump, M.S. Cohen, A.J. McMichael, B.F. Haynes, and G.D. Tomaras, Journal of Virology, 2012. [Epub ahead of print]; PMID[22514337].
[PubMed]. HIV_0413-042612.

9. Structure-based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule HIV-1 Entry Inhibitors. Lalonde, J.M., Y.D. Kwon, D.M. Jones, A.W. Sun, J.R. Courter, T. Soeta, T. Kobayashi, A.M. Princiotto, X. Wu, A. Schon, E. Freire, P.D. Kwong, J.R. Mascola, J. Sodroski, N. Madani, and A.B. Smith, 3rd, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22497421].
[PubMed]. HIV_0413-042612.

10. Synthesis and Antiviral Activity of 6-Deoxycyclopropavir, a New Prodrug of Cyclopropavir. Li, C., D.C. Quenelle, M.N. Prichard, J.C. Drach, and J. Zemlicka, Bioorganic & Medicinal Chemistry, 2012. 20(8): p. 2669-2674; PMID[22417649].
[PubMed]. HIV_0413-042612.

11. Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-infection. Masgala, A., S. Bonovas, and G.K. Nikolopoulos, Mini Reviews in Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22530578].
[PubMed]. HIV_0413-042612.

12. Do Opioids Activate Latent HIV-1 by Down-regulating Anti-HIV microRNAs? Purohit, V., R.S. Rapaka, J. Rutter, and D. Shurtleff, Journal of Neuroimmune Pharmacology, 2012. [Epub ahead of print]; PMID[22527633].
[PubMed]. HIV_0413-042612.

13. Morphine and Galectin-1 Modulate HIV-1 Infection of Human Monocyte-derived Macrophages. Reynolds, J.L., W.C. Law, S.D. Mahajan, R. Aalinkeel, B. Nair, D.E. Sykes, M.J. Mammen, K.T. Yong, R. Hui, P.N. Prasad, and S.A. Schwartz, Journal of Immunology, 2012. 188(8): p. 3757-3765; PMID[22430735].
[PubMed]. HIV_0413-042612.

14. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase. Sohl, C.D., R. Kasiviswanathan, J. Kim, U. Pradere, R.F. Schinazi, W.C. Copeland, H. Mitsuya, M. Baba, and K.S. Anderson, Molecular Pharmacology, 2012. [Epub ahead of print]; PMID[22513406].
[PubMed]. HIV_0413-042612.

15. Perspectives on Developing Small Molecule Inhibitors Targeting HIV-1 Integrase. Tan, J.J., C. Liu, X.H. Sun, X.J. Cong, L.M. Hu, C.X. Wang, and X.J. Liang, Mini Reviews in Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22512579].
[PubMed]. HIV_0413-042612.

16. Synthesis of (6-(13)C)Pyrimidine Nucleotides as Spin-labels for RNA Dynamics. Wunderlich, C.H., R. Spitzer, T. Santner, K. Fauster, M. Tollinger, and C. Kreutz, Journal of the American Chemical Society, 2012. [Epub ahead of print]; PMID[22489874].
[PubMed]. HIV_0413-042612.

17. Second-site Suppressors of HIV-1 Capsid Mutations: Restoration of Intracellular Activities without Correction of Intrinsic Capsid Stability Defects. Yang, R., J. Shi, I.J. Byeon, J. Ahn, J.H. Sheehan, J. Meiler, A.M. Gronenborn, and C. Aiken, Retrovirology, 2012. 9(1): p. 30; PMID[22515365].
[PubMed]. HIV_0413-042612.

ISI Web of Knowledge citations

18. HIV Pol Inhibits HIV Budding and Mediates the Severe Budding Defect of Gag-Pol. Gan, X. and S.J. Gould, Plos One, 2012. 7(1); ISI[000301123400056].
[WOS]. HIV_0413-042612.

19. Systemic Inhibition of Myeloid Dendritic Cells by Circulating HLA Class I Molecules in HIV-1 Infection. Huang, J.H., M. Al-Mozaini, J. Rogich, M.F. Carrington, K. Seiss, F. Pereyra, M. Lichterfeld, and X.G. Yu, Retrovirology, 2012. 9; ISI[000301719500001].
[WOS]. HIV_0413-042612.

20. Short Cyclic Peptides Derived from the C-terminal Sequence of Alpha 1-antitrypsin Exhibit Significant anti-HIV-1 Activity. Jia, Q.Y., X.F. Jiang, F. Yu, J.Y. Qiu, X.Y. Kang, L.F. Cai, L. Li, W.G. Shi, S.W. Liu, S.B. Jiang, and K.L. Liu, Bioorganic & Medicinal Chemistry Letters, 2012. 22(7): p. 2393-2395; ISI[000301846100005].
[WOS]. HIV_0413-042612.

21. A Novel 3,4-Dihydropyrimidin-2(1H)-one: HIV-1 Replication Inhibitors with Improved Metabolic Stability. Kim, J., T. Ok, C. Park, W. So, M. Jo, Y. Kim, M. Seo, D. Lee, S. Jo, Y. Ko, I. Choi, Y. Park, J. Yoon, M.K. Ju, J. Ahn, S.J. Han, T.H. Kim, J. Cechetto, J. Namc, M. Liuzzi, P. Sommer, and Z. No, Bioorganic & Medicinal Chemistry Letters, 2012. 22(7): p. 2522-2526; ISI[000301846100032].
[WOS]. HIV_0413-042612.

22. Identification of anti-HIV and anti-Reverse Transcriptase activity from Tetracera scandens. Kwon, H.S., J.A. Park, J.H. Kim, and J.C. You, Bmb Reports, 2012. 45(3): p. 165-170; ISI[000302257100006].
[WOS]. HIV_0413-042612.

23. A Flexible Model of HIV-1 Latency Permitting Evaluation of Many Primary CD4 T-Cell Reservoirs. Lassen, K.G., A.M. Hebbeler, D. Bhattacharyya, M.A. Lobritz, and W.C. Greene, Plos One, 2012. 7(1); ISI[000301639600006].
[WOS]. HIV_0413-042612.

24. Hydrophobic Core Flexibility Modulates Enzyme Activity in HIV-1 Protease. Mittal, S., Y.F. Cai, M.N.L. Nalam, D.N.A. Bolon, and C.A. Schiffer, Journal of the American Chemical Society, 2012. 134(9): p. 4163-4168; ISI[000301550800054].
[WOS]. HIV_0413-042612.

25. DBSA Catalyzed, One-pot Three-component "on Water" Green Protocol for the Synthesis of 2,3-Disubstituted 4-thiazolidinones. Prasad, D., A. Preetam, and M. Nath, Rsc Advances, 2012. 2(7): p. 3133-3140; ISI[000301459900078].
[WOS]. HIV_0413-042612.

26. Thioredoxin-1 and Protein Disulfide Isomerase Catalyze the Reduction of Similar Disulfides in HIV gp120. Reiser, K., K.O. Francois, D. Schols, T. Bergman, H. Jornvall, J. Balzarini, A. Karlsson, and M. Lundberg, International Journal of Biochemistry & Cell Biology, 2012. 44(3): p. 556-562; ISI[000301914100019].
[WOS]. HIV_0413-042612.

27. Synthesis of Fused Indazole Ring Systems and Application to Nigeglanine hydrobromide. Sather, A.C., O.B. Berryman, and J. Rebek, Organic Letters, 2012. 14(6): p. 1600-1603; ISI[000301516000061].
[WOS]. HIV_0413-042612.

28. Optimization of 2,4-Diarylanilines as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Sun, L.Q., B.J. Qin, L. Huang, K.D. Qian, C.H. Chen, K.H. Lee, and L. Xie, Bioorganic & Medicinal Chemistry Letters, 2012. 22(7): p. 2376-2379; ISI[000301846100001].
[WOS]. HIV_0413-042612.

29. A Facile and Efficient Iodination of 5,6-di(Arylamino)pyridine-2,3-diones. Xie, W.L., Y. Zhou, C.P. Xiao, L. Xie, X.F. Tang, and R.Y. Liu, Journal of Chemical Research, 2012(2): p. 103-104; ISI[000301903300012].
[WOS]. HIV_0413-042612.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022